Bexson Issued USPTO Patent on Proprietary Formulation Technology, SEVALENT
09 Jan 2023 //
PR NEWSWIRE
Bexson Biomedical Announces Robert Langer Joins Its Scientific Advisory Board
20 Sep 2022 //
FIRSTWORLDPHARMA
Bexson Announces Robert S. Langer ScD, Joins Its Scientific Advisory Board
20 Sep 2022 //
PRNEWSWIRE
Bexson Announces Participation in Jeffries Innovation in Mental Health Summit
08 Sep 2022 //
PRNEWSWIRE
BEXSON BIOMEDICAL TO PRESENT AT ARROWHEAD PUBLISHERS` 2ND ANNUAL CONFERENCE
23 May 2022 //
PRNEWSWIRE
Stevanato and Bexson Expand Collaboration to Treat Mental Health Conditions
29 Apr 2022 //
BUSINESSWIRE
Bexson Announces Expansion to Treat Major Depression with Wearable Ketamine
18 Nov 2021 //
PRNEWSWIRE
Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation
29 Apr 2021 //
PRNEWSWIRE